Longfellow, as I understand it, NWBO does not make the revisions themselves to the EU and UK clinical trial sites, but rather the regulators themselves do. In fact, the company was surprised (as we all were) when the SAP changes were reflected on those two sites.
The US and Canadian sites are administered by the clinical trial sponsors, so NWBO is responsible for making any changes to their trial site. They’ve obviously opted to not update the US P3 clinical trial site for quite some time now, perhaps for some strategic reason that we all are not privy to, and so those two sites remain unchanged. I believe Canada is possibly tied to the US one (?) so I don’t think it will be updated until the US one is.
I do think the company eventually intends to update it, maybe after top line?
News 
Market Data 
Discover 
